The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Small Volume Parenteral Market During 2026–2030?
The small volume parenteral market has demonstrated significant growth over recent years. It is anticipated to increase from $191.36 billion in 2025 to $207.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The historical expansion can be linked to the increasing adoption of injectable therapies, the broader scope of hospital-based drug administration, the accessibility of glass ampule packaging, the proliferation of acute care treatments, and a growing need for parenteral nutrition.
The small volume parenteral market is anticipated to experience robust expansion in the coming years. By 2030, this market is projected to reach a value of $275.99 billion, expanding at a compound annual growth rate (CAGR) of 7.4%. Key factors contributing to this projected growth include a heightened demand for biologics and vaccines, an uptick in the use of self-injectable treatments, an increase in aseptic manufacturing capabilities, a greater emphasis on sophisticated drug delivery mechanisms, and enhanced financial commitments to sterile packaging solutions. Prominent trends during this period are expected to encompass wider acceptance of prefilled syringe designs, an escalating need for sterile injectable medications, increased utilization of single-dose parenteral products, the broadening scope of vaccine and biologic administration, and a heightened emphasis on ensuring drug safety and stability.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Which Key Drivers Are Affecting The Small Volume Parenteral Market Development?
The small-volume parenteral market is anticipated to expand due to the rising volume of surgical procedures. Surgery is a medical specialty that involves using operative techniques to investigate or treat a pathological condition like disease or injury, improve bodily function or appearance, or repair unwanted ruptured areas. The frequency of surgeries is increasing, driven by advancements in medical technology and an aging population, which in turn boosts the demand for surgical interventions. Small-volume parenteral solutions are utilized in surgeries for the precise administration of medications, electrolytes, and nutrients directly into the bloodstream. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the growing number of surgeries is driving the growth of the small-volume parenteral market.
How Are Segments Identified Within The Small Volume Parenteral Market Segment Framework?
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorders, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
What Trends Are Transforming The Small Volume Parenteral Market?
Companies operating within the **small-volume parenteral market** are prioritizing the development of innovative solutions, such as prefilled, ready-to-use injectable formulations, aimed at improving dosing accuracy, reducing contamination risks, and enhancing patient safety. These prefilled, ready-to-use injectable formulations are medications supplied already measured in a sterile syringe or vial, allowing healthcare providers to administer the drug directly without additional preparation. For example, in **June 2025**, **Gland Pharma Limited**, an **India**-based pharmaceutical company focused on generic injectables, received approval from the **U.S. Food and Drug Administration (USFDA)** for its **Abbreviated New Drug Application (ANDA)** for **Angiotensin II Acetate Injection 2.5 mg/mL**. This injection is indicated for swiftly increasing blood pressure in adults suffering from septic or distributive shock when conventional therapies are insufficient. It functions by binding to vascular smooth muscle receptors, inducing vasoconstriction, and promoting aldosterone release, with a rapid effect that typically achieves target blood pressure within **five minutes**. Given intravenously, the dosage is carefully titrated to maintain the desired blood pressure, providing essential support for patients who remain hypotensive despite fluid resuscitation and vasopressor therapy.
Who Are The Companies Competing Within The Small Volume Parenteral Market?
Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
Get The Full Small Volume Parenteral Market Report:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Which Region Has The Greatest Market Share In The Small Volume Parenteral Market?
North America was the largest region in the small volume parenteral market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Small Volume Parenteral Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Browse Through More Reports Similar to the Global Small Volume Parenteral Market 2026, By The Business Research Company
Parenteral Nutrition Market Report 2026
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
Small Volume Parenteral Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Large Volume Parenteral Lvp Market Report 2026
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model